France is set to become a global leader in using AI to diagnose and
treat diseases through €33 million Owkin-led AI project
Paris, 31st March 2023 – France is set to become a global leader in artificial intelligence-powered precision medicine through a new €33 million Bpifrance-funded consortium project led by French AI biotech company Owkin.
Born from a collaboration between Owkin and Gustave Roussy, Europe’s leading cancer hospital, PortrAIt will see research hospitals and pathology labs across France working with French technology leaders to develop and deploy new digital pathology AI tools to improve cancer treatment. The project aims to build at least 15 AI-based tools to improve the diagnosis of cancer, the discovery of new treatment biomarkers and the prediction of patient outcomes in hospitals across France.
Gustave Roussy, Centre Léon Bérard, Unicancer and other French comprehensive cancer centres will work closely with Owkin, French digital imaging company Tribun Health, and French pathology diagnostics group CYPATH to usher in a new era of precision medicine.